Haplotype analysis of tumour necrosis factor receptor genes in 1p36: No evidence for association with systemic lupus erythematosus

European Journal of Human Genetics

Volumn 14, Issue 1, 2006, Pages 69-78

  Chadha, Sapna ^a   Miller, Katie ^b   Farwell, Lisa ^b   Sacks, Steven ^c   Daly, Mark J ^b   Rioux, John D ^b   Vyse, Timothy J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

CD120B; CD30; Haplotype; HVEM; LD; SLE; SNP; TNFR

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; EUROPE; FAMILY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED KINGDOM;

ANTIGENS, CD30; CHROMOSOMES, HUMAN, PAIR 1; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GREAT BRITAIN; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECEPTORS, VIRUS;

EID: 29644440938     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201527     Document Type: Article

References (55)

1. Kotzin BL: Systemic lupus erythematosus. Cell 1996; 85: 303-306.
2. Hochberg MC: Systemic lupus erythematosus. Rheum Dis Clin N Am 1990; 16: 617-639.
3. Blatt NB, Glick GD: Anti-DNA autoantibodies and systemic lupus erythematosus. Pharmacol Ther 1999; 83: 125-139.
4. Deapen D, Escalante A, Weinrib L et al: A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311-318.
5. Gaffney PM, Kearns GM, Shark KB et al: A genome-wide search for susceptibility genes in human systemic lupus erythematosus sibpair families. Proc Natl Acad Sci USA 1998; 95: 14875-14879.
6. Gaffney PM, Ortmann WA, Selby SA et al: Genome screening in human systemic lupus erythematosus: Results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000; 66: 547-556.
7. Shai R, Quismorio Jr FP, Li L et al: Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 1999; 8: 639-644.
8. Moser KL, Neas BR, Salmon JE et al: Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95: 14869-14874.
9. Lindqvist AK, Steinsson K, Johanneson B et al: A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 2000; 14: 169-178.
10. Johanneson B, Lima G, von SJ, arcon-Segovia D, arcon-Riquelme ME: A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. Am J Hum Genet 2002; 71: 1060-1071.
11. Vyse TJ, Kotzin BL: Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998; 16: 261-292.
12. Montgomery RI, Warner MS, Lum BJ, Spear PG: Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996; 87: 427-436.
13. Kurts C, Carbone FR, Krummel MF, Koch KM, Miller JF, Heath WR: Signalling through CD30 protects against autoimmune diabetes mediated by CD8T cells. Nature 1999; 398: 341-344.
14. Gabay C, Cakir N, Moral F et al: Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 1997; 24: 303-308.
15. Komata T, Tsuchiya N, Matsushita M, Hagiwara K, Tokunaga K: Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 1999; 53: 527-533.
16. Tsuchiya N, Komata T, Matsushita M, Ohashi J, Tokunaga K: New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus. Genes Immun 2000; 1: 501-503.
17. Siegmund T, Armitage N, Wicker LS, Peterson LB, Todd JA, Lyons PA: Analysis of the mouse CD30 gene: A candidate for the NOD mouse type 1 diabetes locus Idd9.2. Diabetes 2000; 49: 1612-1616.
18. Chakrabarty S, Nagata M, Yasuda H et al: Critical roles of CD30/CD30L interactions in murine autoimmune diabetes. Clin Exp Immunol 2003; 133: 318-325.
19. Tan EM, Cohen AS, Fries JF et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatism 1982; 25: 1271-1277.
20. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatism 1997; 40: 1725.
21. Roberton CA, Vyse TJ: The genetics of systemic lupus erythematosus. Exp Nephrol 2000; 8: 194-202.
22. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN: Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol 1985; 62: 738-745.
23. Sambrook J, Fritsch E, Maniatis T: Analysis and Cloning of Eukaryotic Genomic DNA, Molecular Cloning: A Laboratory Manual, Vol. 9. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989, p 16.
24. Tang K, Opalsky D, Abel K et al: Single nucleotide polymorphism analyses by MALDI-TOF MS. Int J Mass Spectrometry 2003; 226: 37-54.
25. Chadha S, Miller K, Farwell L et al: Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus. Eur J Hum Genet 2005; 13: 669-676.
26. O'CoAnell JR, Weeks DE: PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.
27. BarreAt JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
28. Gabriel SB, Schaffner SF, Nguyen H et al: The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
29. Hedrick PW: Gametic disequiPibrium measures: proceed with caution. Genetics 1987; 117: 331-341.
30. Qin ZS, Niu T, Liu JS: Partition - ligation - expectation - maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 2002; 71: 1242-1247.
31. Martin ER, Monks SA, Warren LL, Kaplan NL: A test for linkage and association in general pedigrees: The pedigree disequilibrium test. Am J Hum Genet 2000; 67: 146-154.
32. Reich DE, Cargill M, Bolk S et al: Linkage disequilibrium in the human genome. Nature 2001; 411: 199-204.
33. Glenn CL, Wang WY, Benjafield AV, Morris BJ: Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor. Hum Mol Genet 2000; 9: 1943-1949.
34. Ahmed S, Ihara K, Bassuny WM et al: Association study between CD30 and CD30 ligand genes and type 1 diabetes in the Japanese population. Genes Immun 2002; 3: 96-101.
35. Al Ansari AS, Ollier WE, Villarreal J, Ordi J, Teh LS, Hajeer AH: Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus. Tissue Antigens 2000; 55: 97-99.
36. Sullivan KE: Genetics of systemic lupus erythematosus. Clinical implications. Rheum Dis Clin N Am 2000; 26: 229-256, v-vi.
37. Takahashi M, Hashimoto H, Akizuki M et al: Lack of association between the Met196Arg polymorphism in the TNFR2 gene and autoimmune diseases accompanied by vasculitis including SLE in Japanese. Tissue Antigens 2001; 57: 66-69.
38. Lee EB, Yoo JE, Lee YJ, Choi YJ, Park KS, Song YW: Tumor necrosis factor receptor 2 polymorphism in systemic lupus erythematosus: No association with disease. Hum Immunol 2001; 62: 1148-1152.
39. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG: The biallelic variable number of tandem repeats of the tumor necrosis factor receptor 2 promoter in systemic lupus erythematosus. Rheumatol Int 2003; 23: 108-111.
40. Sashio H, Tamura K, Ito R et al: Polymorphisms of the TNF gene and the TNF receptor superfamily member 1 B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics 2002; 53: 1020-1027.
41. Geurts JM, Janssen RG, van Greevenbroek MM et al: Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia. Hum Mol Genet 2000; 9: 2067-2074.
42. Albagha OM, Tasker PN, McGuigan FE, Reid DM, Ralston SH: Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women. Hum Mol Genet 2002; 11: 2289-2295.
43. Spotila LD, Rodriguez H, Koch M et al: Association analysis of bone mineral density and single nucleotide polymorphisms in two candidate genes on chromosome 1p36. Calcif Tissue Int 2003; 73: 140-146.
44. Tasker PN, Albagha OM, Masson CB, Reid DM, Ralston SH: Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture. Osteoporos Int 2004; 15: 903-908, [E-pub April 8, 2004].
45. Dieude P, Petit E, Cailleau-Moindrault S et al: Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: Evidence for genetic heterogeneity. Arthritis Rheum 2002; 46: 2039-2044.
46. Van Der Helm-Van Mil AH, Dieude P, Schonkeren JJ, Cornelis F, Huizinga TW: No association between tumour necrosis factor receptor type 2 gene polymorphism and rheumatoid arthritis severity: A comparison of the extremes of phenotypes. Rheumatology (Oxford) 2004; 43: 1232-1234.
47. Glossop JR, Nixon NB, Dawes PT, Hassell AB, Mattey DL: No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis. J Rheumatol 2003; 30: 1406-1409.
48. Peral B, San Millan JL, Castello R, Moghetti P, Escobar-Morreale HF: Comment: The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism. J Clin Endocrinol Metab 2002; 87: 3977-3983.
49. Barton A, John S, Ollier WE, Silman A, Worthington J: Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. Arthritis Rheum 2001; 44: 61-65.
50. Tsuchiya N, Kawasaki A, Tsao BP, Komata T, Grossman JM, Tokunaga K: Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun 2001; 2: 317-322.
51. Bridges Jr SL, Jenq G, Moran M, Kuffner T, Whitworth WC, McNicholl J: Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences. Arthritis Rheum 2002; 46: 2045-2050.
52. GemuAd C, Ramu C, tenberg-Greulich B, Gibson TJ: Gene2EST: a BLAST2 server for searching expressed sequence tag (EST) databases with eukaryotic gene-sized queries. Nucl Acids Res 2001; 29: 1272-1277.
53. RutSerford K, Parkhill J, Crook J et al: Artemis: sequence visualization and annotation. Bioinformatics 2000; 16: 944-945.
54. Akesaka T, Lee SG, Ohashi J et al: Comparative study of the haplotype structure and linkage disequilibrium of chromosome 1p36.2 region in the Korean and Japanese populations. J Hum Genet 2004; 49: 603-609, [E-pub October 6, 2004].
55. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.